Brian G. Feagan

机构：Western University, Alion Science and Technology (United States), London Health Sciences Centre, Align Technology (United States), University Gastroenterology, University College London, University of Cincinnati Medical Center, Western University of Health Sciences · ORCID：0000-0002-6914-3822

发表论文 1251 篇 · 总被引 92163 次 · h-index 137

代表论文

• Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 28)
• Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 20)
• An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease (2025 · Gastroenterology · 被引 7)
• Development and validation of a novel Endoscopic ulcer Activity Score for Evaluation of Crohn's Disease (EASE-CD) using data from two randomised controlled trials (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 6)
• Recommendations to Standardize the Conduct of Clinical Trials Evaluating Novel Therapies for Perianal Fistulizing Crohn’s Disease (2025 · Clinical Gastroenterology and Hepatology · 被引 5)
• Placebo rates in randomized clinical trials of ulcerative colitis: an individual patient data meta-analysis (2025 · Journal of Crohn s and Colitis · 被引 3)